Cited by 426Ovarian function and disordersPancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

Open access

Ehrmann, D A, Sturis, J, Byrne, M M, Karrison, T, Rosenfield, R L, Polonsky, K S·1995·Journal of Clinical Investigation

DOI 10.1172/jci118064PMC PMC185226

Open this paper in CoChat — free account Open PDF

Abstract

The increased prevalence of non-insulin-dependent diabetes mellitus (NIDDM) among women with polycystic ovary syndrome (PCOS) has been ascribed to the insulin resistance characteristic of PCOS. This study was undertaken to determine the role of defects in insulin secretion as well as familial factors to the predisposition to NIDDM seen in PCOS. We studied three groups of women: PCOS with a family history of NIDDM (PCOS FHx POS; n = 11), PCOS without a family history of NIDDM (PCOS FHx NEG; n = 13), and women without PCOS who have a family history of NIDDM (NON-PCOS FHx POS; n = 8). Beta cell function was evaluated during a frequently sampled intravenous glucose tolerance test, by a low dose graded glucose infusion, and by the ability of the beta cell to be entrained by an oscillatory glucose infusion. PCOS FHx POS women were significantly less likely to demonstrate appropriate beta cell compensation for the degree of insulin resistance. The ability of the beta cell to entrain, as judged by the spectral power for insulin secretion rate, was significantly reduced in PCOS FHx POS subjects. In conclusion, a history of NIDDM in a first-degree relative appears to define a subset of PCOS subjects with a greater prevalence of insulin secretory defects. The risk of developing NIDDM imparted by insulin resistance in PCOS may be enhanced by these defects in insulin secretion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci118064

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Spectral Analysis and its Applications.
Freiberger, W. F., Jenkins, G. M., & Watts, D. G. (1969) · Journal of the American Statistical Association · doi:10.2307/2286100 · Cited by 4,990
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,197
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of pima indians
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study
Martin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158
Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents
Warram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach
Bergman, R. N. (1989) · Diabetes · doi:10.2337/diab.38.12.1512 · Cited by 1,001

Flagged first, then by citations

Show all 52 references

Research works printed but not linked: 3

Dunaif, J. R. Givens, F. P. Haseltine, and G. R. Merriam, editors. Blackwell Scientific, Cambridge, MA. 347-358.
Dunaif, A., G. Green, and D. Finegood. 1992. Pancreatic beta (B) cell function is normal in insulin resistant women with the polycystic ovary syndrome (PCOS). Proc. Endocrine Soc., 74th Annual Meeting, San Antonio, TX. 280a (Abstr.)
Ehrmann, D. A., M. Byrne, J. Sturis, R. L. Rosenfield, and K. S. Polonsky. 1994. ,8-Cell dysfunction in polycystic ovary syndrome (PCOS): evidence for a genetic basis. Proc. Endocrine Soc., 76th Annual Meeting, Anaheim, CA. 835a(Abstr.)

Sorted by citations

Items 301–400 of 426

Regulation of Insulin Secretion in Vivo
Vidal, J., & Kahn, S. E. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1597-5_7 · Cited by 7
Genetic contributions to glucose intolerance in polycystic ovary syndrome
Ehrmann, D. A. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62106-2 · Cited by 7
Self-citation
Prevention of Type 2 Diabetes Mellitus
Simpson, R. W., Tuomilehto, J. O., Lindström, J., Shaw, J. E., & Zimmet, P. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1118 · Cited by 7
Effects of insulin-lowering drugs in PCOS: endocrine, metabolic and inflammatory aspects
Rautio, K. (2006) · Cited by 7
Previous adverse pregnancy events as a predictor of gestational diabetes mellitus in Southern Ethiopia: a case control study
Taye, H., Kabthymer, R. H., Hailu, S., Meshesha, M. D., Kanno, G. G., Bayisa, Y., & Molla, W. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2083399 · Cited by 6
Resistencia a la insulina, obesidad y síndrome metabólico en el síndrome del ovario poliquístico
Gambineri, A., & Pasquali, R. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71168-8 · Cited by 6
Effect of PCOS on glucose metabolism
Bennal, A. S., & Kerure, S. (2013) · National Journal of Physiology Pharmacy and Pharmacology · doi:10.5455/njppp.2013.3.220420132 · Cited by 6
Die Insulinresistenz beim polyzystischen Ovar-Syndrom
Schröder, A. K., Tauchert, S., Ortmann, O., Diedrich, K., & Weiss, J. M. (2003) · Wiener klinische Wochenschrift · doi:10.1007/bf03041041 · Cited by 6
Introduction
Tobin, B. W., & Miller, G. D. (2001) · Journal of Nutrition · doi:10.1093/jn/131.2.333s · Cited by 6
Insulin resistance and insulin secretion in childhood and adolescence
Arslanian, S. A. (2003) · CRC Press eBooks · doi:10.3109/9780203633120-7 · Cited by 6
Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
Barnes, R. B., Ehrmann, D. A., & Rosenfield, R. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00132-5 · Cited by 6
Self-citation
RETRACTED: Whey protein preload enhances the active GLP-1 response and reduces circulating glucose in women with polycystic ovarian syndrome
Rao, M., Zumbro, E. L., Broughton, K. S., & LeMieux, M. J. (2021) · Nutrition Research · doi:10.1016/j.nutres.2021.06.005 · Cited by 5
Retracted
Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention
Mani, H., Khunti, K., Levy, M. J., & Davies, M. J. (2013) · Diabetes Management · doi:10.2217/dmt.13.54 · Cited by 5
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00022-6 · Cited by 4
Polycystic ovarian syndrome: Assessment of approaches to diagnosis and cardiometabolic monitoring in UK primary care
Heald, A. H., Livingston, M. A., Holland, D., Robinson, J. C., Moreno, G. Y., Donnahey, G., Duff, C. J., Wu, P., & Fryer, A. A. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.13046 · Cited by 5
[Chronic complications of polycystic ovary syndrome. Review].
Velásquez, E. (2002) · PubMed · Cited by 5
Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome
Jones, M. R., Wilson, S. G., Mullin, B. H., Mead, R., Dudbridge, F., Watts, G. F., & Stuckey, B. G. A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.10.079 · Cited by 6
A new perspective in diagnosing polycystic ovary syndrome.
Ertörer, M. E., Anaforoğlu, İ., Bozkırlı, E., Bakıner, O., Tütüncü, N. B., & Demirağ, N. G. (2007) · PubMed Central · Cited by 5
Polycystic ovarian syndrome: a new perspective.
Ahmed, Y., Akhtar, A. S. M., Qureshi, F., Qureshi, F., Anjum, Q., & Anhalt, H. (2003) · PubMed · Cited by 5
Aspectos neuroendócrinos na síndrome dos ovários policísticos
Nácul, A. P., Comim, F. V., & Spritzer, P. M. (2003) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302003000400015 · Cited by 5
Implications of Insulin Resistance / Hyperinsulinemia on Reproductive Function in Infertile Women with Polycystic Ovary Syndrome
Sakumoto, T., Tokunaga, Y., Terada, Y., Tanaka, H., Nohara, M., Nakaza, A., & Higashi, M. (2012) · InTech eBooks · doi:10.5772/25987 · Cited by 3
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00020-6 · Cited by 5
Attenuation of hyperinsulinemia in polycystic ovary syndrome: What are the options?
Ehrmann, D. A. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350790 · Cited by 4
Self-citation
The polycystic ovary syndrome: a position statement from the European Society of
Conway, G. S., Dewailly, D., Diamanti‐Kandarakis, E., Franks, S., Gambineri, A., Keleştimur, F., Μacut, D., Micić, D., Pasquali, R., Pfeifer, M., et al. (2014) · Cited by 3
An Update on the Genetics of Polycystic Ovary Syndrome
Sharma, P., Jain, M., Tripathi, M. K., Sharma, M., & Halder, A. (2024) · Journal of Endocrinology & Reproduction · doi:10.18311/jer/2023/34654 · Cited by 3
The link between polycystic ovary syndrome and Type 2 diabetes: what do we know today?
Sathyapalan, T., & Atkin, S. L. (2011) · Diabetes Management · doi:10.2217/dmt.11.59 · Cited by 3
Clinical Evaluation of Polycystic Ovary Syndrome
Taylor, A. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_31 · Cited by 3
STUDY OF ADOLESCENT GIRLS WITH MENSTRUALIRREGULARITIES FOR POLYCYSTIC OVARIES AND INSULIN RESISTANCE
Kumari, S., Pankaj, S., Kavita, K., Choudhary, V., & Raghwendra, K. H. (2015) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2015/802 · Cited by 3
Variability in Estimated Modelled Insulin Secretion
Ormsbee, J. J., Burden, H. J., Knopp, J. L., Chase, J. G., Murphy, R., Shepherd, P. R., & Merry, T. L. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821991120 · Cited by 3
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome—Authors’ Response1
Dunaif, A. E., & Legro, R. S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5939-4 · Cited by 3
Hiperandrogenismo en la mujer diabética: rol de la resistencia insulínica y de la hiperinsulinemia
Tejada, G. G.-R. D., & Escobar-Morreale, H. F. (2003) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(03)74555-0 · Cited by 3
The Role of Leptin in Polycystic Ovary Syndrome
Magoffin, D. A., Duggal, P. S., & Norman, R. J. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0157-2_20 · Cited by 3
ESTUDIOS DE VARIABLES CLÍNICAS Y METABÓLICAS EN MUJERES CON HIPERANDROGENISMO CLÍNICO
Cheviakoff, S., Sergio Carmona, G., & de la P, R. L. M. (2004) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262004000100008 · Cited by 3
Expanding applications for metformin in polycystic ovarian syndrome
LIU, J. H., & Bill, A. H. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.03.016 · Cited by 3
Insulin Resistance
Pasquali, R., & Gambineri, A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_30 · Cited by 3
Insulin Resistance in Children and in the Polycystic Ovarian Syndrome
Bloomgarden, Z. T. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.294 · Cited by 2
Reproduction and Metabolism: Insights from Polycystic Ovary Syndrome
Jasti, P., & Dunaif, A. E. (2012) · Endocrinology and Metabolism · doi:10.3803/enm.2012.27.3.180 · Cited by 2
Efficacy of sequential treatment of metformin and clomiphene citrate in clomiphene resistant women with polycystic ovary syndrome
Neena, C. (2007) · Cited by 2
INSULIN RESISTANCE AND SECRETORY CAPACITY IN YOUNG WOMEN WITH POLYCYSTIC OVARY SYNDROME
Neelaveni, K., & Sahay, R. K. (2016) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2016/1388 · Cited by 2
Studying the Effect of LeutiniZing Hormone and Follicular Stimulating Hormone on Poly Cystic Ovary Syndrome in Married and in Non-married Women
Al-Najjar, E. W. S., Wafeq, S. A. J., & Hussen, N. A.-H. A. A. A. (2014) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v14i1.130 · Cited by 2
Association of serum ferritin with insulin resistance in women with polycystic ovarian syndrome
Begum, T., Ishra, S., Sharifa, B. S., Nahar, S., Begum, H. A., & Khan, S. (2021) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20212936 · Cited by 2
Evaluation of Adiponectin and Hepcidin with some Biochemical Parameters in Sera of Women with Polycystic Ovary Syndrome
Kadhim, S. M., Al-Fartusie, F. S. D., & Кличханов, Н. К. (2023) · Al-Mustansiriyah Journal of Sciences · doi:10.23851/mjs.v34i1.1299 · Cited by 2
Mechanisms and Treatment of Obesity in Polycystic Ovary Syndrome
Pasquali, R., & Gambineri, A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_14 · Cited by 2
Metabolic and lipoprotein aspects of polycystic ovarian syndrome
Pazderska, A., & Gibney, J. (2015) · Clinical Lipidology · doi:10.2217/clp.15.12 · Cited by 2
Women with polycystic ovary syndrome associated with increased anxiety risk: A population-based cohort study in Taiwan
Harnod, T., Tsai, I., Wang, J., Lin, S.-Z., & Ding, D. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.04.032 · Cited by 2
Insulin resistance in polycystic ovary syndrome
Morin-Papunen, L. C. (2000) · Cited by 2
Postprandial Metabolic Responses to Macronutrient in Healthy, Hyperinsulinemic and Type 2 Diabetic Subjects
Lan‐Pidhainy, X. (2012) · TSpace (University of Toronto) · Cited by 2
Insulin Resistance and Hyperinsulinism in the Polycystic Ovary Syndrome
Essah, P. A., & Nestler, J. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_24 · Cited by 1
β-Cell Glucose Sensitivity determines hyperglycaemia in Polycystic Ovary Syndrome
Tomlinson, J., Mari, A., Tura, A., Bond, K., Stenhouse, E., Dew, T. K., Vincent, R. P., & Pinkney, J. H. (2020) · Translational Metabolic Syndrome Research · doi:10.1016/j.tmsr.2020.09.001 · Cited by 1
Prevalence of pre-diabetes and diabetes mellitus in Polycystic Ovarian Syndrome (PCOS)
Ullah, H., Noor, K., & Aziz, A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2216236 · Cited by 1
Metabolic hormonal alterations in functional hypothalamic amenorrhea and anovulation associated with Polycystic ovary syndrome
Jamwal, S., & Soni, A. (2024) · Journal of Applied Pharmaceutical Research · doi:10.18231/j.joapr.2024.12.2.1.15 · Cited by 2
Das polyzystische Ovarsyndrom – Metabolische Konsequenzen
Tan, S., Hahn, S., & Janssen, O. E. (2008) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000111466 · Cited by 1
Section 6: Pulsatile and Phasic Insulin Release in Normal and Diabetic Men Pulsatile Insulin Secretion: Detection, Regulation, and Role in Diabetes
Pørksen, N. K., Hollingdal, M., Juhl, C. B., Butler, P. C., Veldhuis, J. D., & Schmitz, O. (2002) · Cited by 1
Metabolic and clinical characteristics of women with self-reported symptoms of polycystic ovary syndrome
Taponen, S. (2004) · Cited by 1
New Insulin Sensitivity Adjusted β Cell Indices: Validation According to a Genetic Study
Chiu, K. C., Martinez, D. S., Lee, N. P., & Saad, M. F. (2003) · Pancreas · doi:10.1097/00006676-200308000-00019 · Cited by 1
Clinical Features
Stracquadanio, M., & Ciotta, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16760-2_3 · Cited by 1
Obesity, Dysmetabolic and Proinflammatory Milieu of Polycystic Ovary Syndrome
Morong, J. J., & González, F. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_9 · Cited by 1
Glucose Intolerance
Toscano, V. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_16 · Cited by 3
Case Study Responses
LeRoith, D. (2007) · Insulin · doi:10.1016/s1557-0843(07)80063-7 · Cited by 1
Prevalence and Associated Factors of Gestational Diabetes Mellitus Among Pregnant Women Receiving Antenatal Care in Public Health Facilities in Bule Hora, Southern Ethiopia: A Cross-Sectional Study
Boko, W., Abera, R. G., Wolde, M., Gebreegziabher, T., & Demesse, E. S. (2024) · Journal of Medical and Clinical Nursing Studies · doi:10.61440/jmcns.2024.v2.46
Glucose Intolerance in Polycystic Ovary Syndrome
Ehrmann, D. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_20 · Cited by 1
Self-citation
New concepts in pathogenesis and management of polycystic ovarian syndrome: Insulin resistance and role of insulin sensitizers
Yadav, R. P. (1970) · Nepal Journal of Obstetrics and Gynaecology · doi:10.3126/njog.v3i1.1431 · Cited by 1
Синдром поликистозных яичников. Официальное заявление Европейского общества эндокринологии
Conway, G. S., Dewailly, D., & Diamanti‐Kandarakis, E. (2015) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2015.25.32-52 · Cited by 1
Prevalence of Glucose Intolerance in Women with Polycystic Ovary Syndrome: Experience from a Tertiary Care Hospital
Laila, R., Mahmud, N., Nargis, M., & Chowdhury, T. (2016) · BIRDEM Medical Journal · doi:10.3329/birdem.v6i1.28409 · Cited by 1
Long Term Health Problems Caused by Polycystic Ovary Syndrome
Yıldızhan, B., & İlhan, G. A. (2016) · Van Medical Journal · doi:10.5505/vtd.2016.22931 · Cited by 1
Normal Insulin Secretion in Humans
Utzschneider, K. M., Porte, D., & Kahn, S. E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0205 · Cited by 1
Impact of Insufficient Insulin Secretion on Subclinical Glucose Dysregulation
Yamada, C., Mitsuhashi, T., Hiratsuka, N., Inabe, F., Araida, N., & Takahashi, E. (2011) · Ningen dock : official journal of the Japanese Society of Human Dry Dock · doi:10.11320/ningendock.25.37 · Cited by 1
Conceptos básicos sobre infertilidad, incluido el síndrome de poliquistosis ovárica
Brassard, M., Ainmelk, Y., & Baillargeon, J. (2008) · Clínicas médicas de Norteamérica · doi:10.1016/s0186-0194(08)92058-x · Cited by 1
Perfil hormonal e metabólico em pacientes hirsutas com a síndrome dos ovários policísticos
Poy, M., Wiltgen, D., & Spritzer, P. M. (2001) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302001000400007 · Cited by 1
THE GENETICS OF INSULIN RESISTANCE IN FAMILIES WITH POLYCYSTIC OVARY SYNDROME
Matar, J. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Genes Related to Metabolic Abnormalities or Insulin Resistance in Polycystic Ovary Syndrome
Escobar-Morreale, H. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_5 · Cited by 1
Low-density lipoprotein receptor–related protein-5 C/T polymorphism in exon 18 is associated with C peptide and proinsulin levels in control women and patients with polycystic ovary syndrome
Bendlová, B., Vaňková, M., Zajíčková, K., Hill, M., Zemanova, A., Cibula, D., Vejražková, D., Lukášová, P., Včelák, J., Vondra, K., et al. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.076 · Cited by 1
Adipositas und PCO-Syndrom bei jungen Mädchen
Wolf, A. (1998) · Der Gynäkologe · doi:10.1007/pl00003140 · Cited by 1
Type 2 Diabetes Mellitus ‒ Genetics, Diagnosis and Management. Polycystic Ovarian Syndrome
Porter, J., & Barrett, T. G. (2007) · Wiley eBooks · doi:10.1002/9780470692271.ch12 · Cited by 1
Polycystic ovary syndrome and associated metabolic features in indigenous women in the Northern Territory.
Boyle, J. A. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Polycystic Ovary Syndrome and the Metabolic Syndrome
Janssen, O. E., Tan, S., Dietz, T., & Hahn, S. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-37 · Cited by 1
Metformin Improves Glucose Effectiveness, Not Insulin Sensitivity: Predicting Treatment Response in Women With Polycystic Ovary Syndrome
Duran, J. M. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Effect of non-esterified fatty acids on insulin resistance and cardiovascular risk in polycystic ovary syndrome
Aye, M. M. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 1
Beta-Cell Function in Polycystic Ovary Syndrome
Ehrmann, D. A., Sturis, J., Byrne, M. M., Rosenfield, R. L., & Polonsky, K. S. (1996) · Springer eBooks · doi:10.1007/978-1-4613-8483-0_9
Self-citation
Insulin Resistance, Diabetes, and Cardiovascular Risk in Women and the Paradigm of the Polycystic Ovary Syndrome
Pasquali, R., & Gambineri, A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_4
Utilidad de la prueba de tolerancia oral a la glucosa para el cálculo de los índices de sensibilidad a la insulina y su importancia diagnóstica en el síndrome de ovarios poliquísticos
Velázquez-Maldonado, E., Monsalve, Y., Villarroel, V., & Arata-Bellabarba, G. (2005) · Actualidad Contable FACES
Polycystic Ovary Syndrome and Cardiovascular Disease
nder, B., Taner, D., Ylmaz, H., & Muzaffer, M. (2012) · InTech eBooks · doi:10.5772/25519
Bestimmung der Fettgewebstopographie bei weiblichen und männlichen Sterilitätspatienten durch den Lipometer
Giuliani, A. L., Horejsi, R., Möller, R., & Tafeit, E. (2005) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Polycystic Ovarian Syndrome
Shoupe, D. (2010) · Wiley eBooks · doi:10.1002/9781444323030.ch93
The frequency of insulin resistance and hyperlipidaemia in women with polycystic ovarian syndrome (PCOS) attending Inkosi Albert Luthuli Central Hospital .
Magan, N. (2010) · ResearchSpace (University of KwaZulu-Natal)
Characterisation of microparticles and nitro-oxidative stress in cardiometabolic disease
Willis, G. R. (2015) · ORCA Online Research @Cardiff (Cardiff University)
The Genetics of Insulin Resistance: Analysis of the Peroxisome Proliferator-Activated Receptor Pathway
Boudreaux, M. Y. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Endocrine markers of ovarian function: Clinical and biological aspects with focus on Anti Müllerian hormone
Bungum, L. J. (2013) · Lund University Publications (Lund University)
Insulin Action and Secretion in Polycystic Ovary Syndrome
Warren-Ulanch, J., & Arslanian, S. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_11
Peso ao nascimento e Síndrome dos Ovários Policísticos: mais uma associação tardia dentro da reprogramação fetal?
de Melo, A. S. (2009) · doi:10.11606/d.17.2009.tde-26092013-165328
β-Cell Dysfunction and the Onset of Type 2 Diabetes
Fennoy, I. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.01.050
Recommandations pour le diagnostic et le suivi du syndrome des ovaires polykystiques
Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Gynécologie · doi:10.1016/s0246-1064(08)44358-x
Cardiovascular risk in young women with Polycystic OvarySyndrome
Coulson, R.-M. K. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Recomendaciones para el diagnóstico y el seguimiento del síndrome de ovarios poliquísticos
Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(08)70803-8
Polycystic ovary syndrome and metabolic syndrome
Hayden, C. J., & Balen, A. H. (2006) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.1.2.183
AN EVALUATION OF PSYCHOLOGICAL AND SOCIO- DEMOGRAPHIC FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN POLYCYSTIC OVARY SYNDROME CASES AND CONTROLS
Cipkala-Gaffin, J. A. (2009)
Síndrome metabólico (Segunda Parte)
Isaac Crespo, R., Iván Odórico Belzusarri, P., & Aldo Stucchi, G. (2006) · Horizonte Médico (Lima) · doi:10.24265/horizmed.2006.v6n2.07
Síndrome del ovario poliquístico: ¿un camino a la diabetes mellitus?
Petermann, T. S. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74590-8
Case Study Responses
LeRoith, D. (2006) · Insulin · doi:10.1016/s1557-0843(06)80039-4
revisão Aspectos Neuroendócrinos na Síndrome dos Ovários Policísticos
Nácul, A. P., Comim, F. V., & Spritzer, P. M. (2003)

Authors: Ehrmann, D. A., Sturis, J., Byrne, M. M., Karrison, T., Rosenfield, R. L., & Polonsky, K. S.
Affiliations: University of Chicago (US)
ORCID: Sturis, J
Byrne, M M
Karrison, T
Rosenfield, R L
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1995-07-01
Volume: 96
Issue: 1
Pages: 520-527
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci118064
PMC: PMC185226
OpenAlex: W2100224373
Cited by: 426
References: 52
Citations by year: 2025: 1 · 2024: 6 · 2023: 5 · 2022: 12 · 2021: 5 · 2020: 5 · 2019: 9 · 2018: 6 · 2017: 13 · 2016: 11 · 2015: 17 · 2014: 10 · 2013: 12 · 2012: 23
FWCI: 13.28
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (DK 07011-7, T32DK007011)
National Center for Research Resources (RR-00055)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 06308, R01HD006308)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: polycystic ovary syndrome, insulin secretion, insulin resistance, type 2 diabetes, family history of diabetes, beta-cell function, beta-cell compensation, glucose infusion, insulin secretion rate, insulin sensitivity
MeSH terms: Insulin Secretion, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Polycystic Ovary Syndrome, Testosterone, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks